Across the whole pharma sector, there are four or five stocks big one out there which are going to gain market share. So, CDMO is one space within pharma which should do well as we go along. But pharma as a whole space per se has been doing okay and we continue to believe that incrementally also pharma should continue to do well in the coming year also.
Foreign investors continue buying spree; pour Rs 12,921 cr in first week of Aug
In early August, Foreign Portfolio Investors poured Rs 12,921 crore into Indian equities, building on their notable investments from July. This surge indicates improved investor
August 9, 2026